Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Laryngeal Disease: early-phase trial registry
4 of 4 indexed Laryngeal Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 4 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Laryngeal Disease: 4 US clinical trials tracked, 4 recruiting.
Laryngeal Disease is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute on Deafness and Other Communication Disorders (NIDCD), running 1 of these trials.
Enrollment posture brief
Registry condition laryngeal-disease
OPEN 4 | RECR 100% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Laryngeal Disease lists 4 open slots (100% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Laryngeal Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Laryngeal Disease is recruiting above its size-band peers.
4 of 4 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
National Institute on Deafness and Other Communication Disorders (NIDCD)
NCT06303180
Biospecimen Procurement for Head and Neck Disorders
National Cancer Institute (NCI)
NCT03429036
Force Sensor Study
University of California, San Francisco
NCT07434583
Efficacy of Intramuscular Steroid Injection for Chronic Cough.
Medical University of South Carolina
NCT06634823
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Laryngeal Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Laryngeal Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Laryngeal Disease page
4 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Laryngeal Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) sponsors the most Laryngeal Disease trials on record, review their full trial history before evaluating a specific study. See National Institute on Deafness and Other Communication Disorders (NIDCD)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Laryngeal Disease condition card totals 4 registered trials; most-linked intervention Direct laryngoscopy without force modulation; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.